SB 668
Modifies provisions of law relating to certain distributors of hypodermic needles
LR Number:
Last Action:
1/22/2020 - Second Read and Referred S Health and Pensions Committee
Journal Page:
Calendar Position:
Effective Date:
August 28, 2020

Current Bill Summary

SB 668 - Under this act, any entity registered with the Department of Health and Senior Services that possesses, distributes, or delivers hypodermic needles or syringes for the purposes of operating a syringe exchange program or otherwise mitigating health risks associated with unsterile injection drug use shall be exempt from the offense of unlawful distribution, delivery or sale of drug paraphernalia and the offense of unlawful manufacturing with intent to deliver drug paraphernalia.

This act is identical to HCS/HB 168 (2019), substantially similar to HB 1486 (2020) and provisions in HCS/SS/SB 580 (2020), and similar to SCS/HB 1620 (2019).



No Amendments Found.